FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first ...

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...

In THRIVE, Abrams' group recruited participants with moderate-to-severe active thyroid eye disease with proptosis at least 3 ...

Promising early results from the first human clinical trials with new HIV germline-targeting vaccines were reported. These ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...